Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Mehta

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cureus|January 21, 2025
Evaluation of the Safety and Efficacy of Trastuzumab Emtansine (T-DM1) Biosimilar in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: Findings From a Single-Center Retrospective Analysis in IndiaKaushal Patel, Vipulkumar Thummar, Priya Mehta
Current Drug Safety|January 29, 2025
Clomipramine-Induced Urinary Retention in an Adult Male - A Case ReportPriya Mehta, Pooja Sapovadia, Bhargav Purohit
SAGE Open Medical Case Reports|December 5, 2022
Addition of trastuzumab emtansine (T-DM1) in a human epidermal growth factor receptor 2-overexpressed metastatic carcinoma of the gallbladder patient to enhance survival: A case studyViraj Lavingia, Vipulkumar Thummar, Priya Mehta
Cureus|August 1, 2024
A Case Report on Trastuzumab Emtansine (T-DM1) in a Patient With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer and Brain Metastases: Long-Term Treatment and SurvivalVipul Doshi, Vipulkumar Thummar, Priya Mehta
Cureus|April 29, 2024
Nab-Paclitaxel-Based Systemic Approach to Achieving Complete Remission for Relapsed Stage III Endometrial Carcinoma: Insights From the Indian SubcontinentPrasanna Rammohan, Vipulkumar Thummar, Priya Mehta
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 18, 2017
Mealtime behavior among parents and their young children with food allergyLinda Jones Herbert, Priya Mehta, Hemant Sharma
Cureus|May 31, 2023
A Case Report on the Efficacy of Trastuzumab Emtansine in a Patient With Human Epidermal Growth Factor Receptor 2 Exon 20-Mutated Adenocarcinoma of the LungArun Warrier, Anu George, Vipulkumar Thummar, et al.
Reports (MDPI)|July 30, 2025
Favorable Outcome and Safety of Neoadjuvant Trastuzumab Emtansine (T-DM1) in a HER2-Positive Early Breast Cancer Patient with Severe Renal Disease on Hemodialysis Ineligible for Conventional Chemotherapy: A Case ReportSuman Kalyan Natarajan, Joice Crystal Danansezhian, Vipulkumar Thummar, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|February 4, 2015
Feasibility of the SMART Project: A Text Message Program for Adolescents With Type 1 DiabetesLinda Jones Herbert, Priya Mehta, Maureen Monaghan, et al.
Clinical Pediatrics|April 22, 2015
Checking In: A Pilot of a Physician-Delivered Intervention to Increase Parent-Adolescent Communication About Blood Glucose MonitoringMaureen Monaghan, Lauren Clary, Priya Mehta, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cureus|January 21, 2025
Evaluation of the Safety and Efficacy of Trastuzumab Emtansine (T-DM1) Biosimilar in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: Findings From a Single-Center Retrospective Analysis in IndiaKaushal Patel, Vipulkumar Thummar, Priya Mehta
Current Drug Safety|January 29, 2025
Clomipramine-Induced Urinary Retention in an Adult Male - A Case ReportPriya Mehta, Pooja Sapovadia, Bhargav Purohit
SAGE Open Medical Case Reports|December 5, 2022
Addition of trastuzumab emtansine (T-DM1) in a human epidermal growth factor receptor 2-overexpressed metastatic carcinoma of the gallbladder patient to enhance survival: A case studyViraj Lavingia, Vipulkumar Thummar, Priya Mehta
Cureus|August 1, 2024
A Case Report on Trastuzumab Emtansine (T-DM1) in a Patient With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer and Brain Metastases: Long-Term Treatment and SurvivalVipul Doshi, Vipulkumar Thummar, Priya Mehta
Cureus|April 29, 2024
Nab-Paclitaxel-Based Systemic Approach to Achieving Complete Remission for Relapsed Stage III Endometrial Carcinoma: Insights From the Indian SubcontinentPrasanna Rammohan, Vipulkumar Thummar, Priya Mehta
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 18, 2017
Mealtime behavior among parents and their young children with food allergyLinda Jones Herbert, Priya Mehta, Hemant Sharma
Cureus|May 31, 2023
A Case Report on the Efficacy of Trastuzumab Emtansine in a Patient With Human Epidermal Growth Factor Receptor 2 Exon 20-Mutated Adenocarcinoma of the LungArun Warrier, Anu George, Vipulkumar Thummar, et al.
Reports (MDPI)|July 30, 2025
Favorable Outcome and Safety of Neoadjuvant Trastuzumab Emtansine (T-DM1) in a HER2-Positive Early Breast Cancer Patient with Severe Renal Disease on Hemodialysis Ineligible for Conventional Chemotherapy: A Case ReportSuman Kalyan Natarajan, Joice Crystal Danansezhian, Vipulkumar Thummar, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|February 4, 2015
Feasibility of the SMART Project: A Text Message Program for Adolescents With Type 1 DiabetesLinda Jones Herbert, Priya Mehta, Maureen Monaghan, et al.
Clinical Pediatrics|April 22, 2015
Checking In: A Pilot of a Physician-Delivered Intervention to Increase Parent-Adolescent Communication About Blood Glucose MonitoringMaureen Monaghan, Lauren Clary, Priya Mehta, et al.
Pageof 3